Suppr超能文献

一例颅底骨髓炎病原体检测的历程:发现新大陆!

A pathogen-detection's odyssey in a case of skull base osteomyelitis: Land ahoy!

作者信息

Althaus Laurenz, Joost Insa, Schaumann Katharina, Prinzen Tom, Werminghaus Maika, Thyson Susann, Henrich Birgit, Schipper Jörg, Klenzner Thomas

机构信息

Department of Otorhinolaryngology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf, Germany.

Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf, Germany.

出版信息

Ann Clin Microbiol Antimicrob. 2025 Apr 26;24(1):29. doi: 10.1186/s12941-025-00796-6.

Abstract

BACKGROUND

Skull base osteomyelitis (SBO) is a severe disease not only because of its rapid progression and its high mortality: diagnosis and treatment are often protracted and in more than 30% of cases no causative pathogen can be detected. SBO is usually preceded by immunodeficiency, which is why opportunistic infections caused by atypical pathogens must also be taken into consideration. In consideration of the different possible entities, an interdisciplinary approach with surgical debridement, pathological sampling, microbiological testing and antimicrobiological therapy is indispensable.

CASE PRESENTATION

We report on a 58-year-old female patient who presented to our clinic for the first time in 2014 with a bilateral skull base osteomyelitis. The patient had a history of several comorbidities, including hypogammaglobulinemia following the successful treatment of a relapsed B-CLL. Different surgical treatments had already been attempted at the time of initial presentation. Several rheumatological, orthopedic, haemato-oncological and divergent microbiological differential diagnoses could be ruled out. Despite various interdisciplinary treatment attempts (including surgery, antibiotic therapies and hyperbaric oxygen therapy) the progress led to a palsy of the caudal cranial nerve group in 2022. With all preceded microbiological sampling being negative, we initiated species specific PCRs covering atypical organisms. An atypical infection of Mycoplasma pneumoniae was detected. After starting antibiotic therapy with azithromycin and doxycycline the progress could be halted and the palsies were regredient. The following MRI scans confirmed a decline in findings.

CONCLUSIONS

To the authors' knowledge, this case report is the first description of SBO as an extrapulmonary M. pneumoniae infection. It shows the diagnostic and therapeutic complexity of a multifaceted clinical picture in which immunological, microbial and ENT-surgical diagnostic and therapeutic concepts must be regularly coordinated. Against the background of the high proportion of missing pathogens up to 30%, interdisciplinary cooperation within the framework of the ABS concept is emphasized. Structured and interdisciplinary diagnostics by a skull base center specializing in this field was ultimately decisive for treatment in this case.

摘要

背景

颅底骨髓炎(SBO)是一种严重疾病,不仅因其进展迅速且死亡率高,还因为其诊断和治疗往往迁延,超过30%的病例无法检测到致病病原体。SBO通常 preceded by免疫缺陷,这也是为何必须考虑由非典型病原体引起的机会性感染。鉴于不同的可能病因,采用手术清创、病理取样、微生物检测和抗菌治疗的多学科方法必不可少。

病例报告

我们报告了一名58岁女性患者,她于2014年首次到我们诊所就诊,患有双侧颅底骨髓炎。该患者有多种合并症病史,包括复发性B淋巴细胞慢性淋巴细胞白血病成功治疗后出现的低丙种球蛋白血症。初次就诊时已尝试过不同的手术治疗。可以排除几种风湿性、骨科、血液肿瘤学和不同的微生物学鉴别诊断。尽管进行了各种多学科治疗尝试(包括手术、抗生素治疗和高压氧治疗),病情进展仍在2022年导致尾侧颅神经组麻痹。由于之前所有微生物取样均为阴性,我们启动了针对非典型生物体的物种特异性PCR检测。检测到肺炎支原体非典型感染。开始使用阿奇霉素和强力霉素进行抗生素治疗后,病情进展得以停止,麻痹症状逐渐好转。随后的MRI扫描证实了病情的改善。

结论

据作者所知,本病例报告是将SBO描述为肺外肺炎支原体感染的首例。它展示了多方面临床表现的诊断和治疗复杂性,其中免疫、微生物和耳鼻喉科手术的诊断和治疗概念必须定期协调。鉴于高达30%的病原体缺失比例较高,强调在ABS概念框架内进行多学科合作。在这种情况下,由专门从事该领域的颅底中心进行结构化和多学科诊断最终对治疗起了决定性作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验